Oral Oncology
Volume 37, Issue 6 , Pages 527-536, September 2001

Characterization of four cell lines derived from a human malignant fibrous histiocytoma of the maxillary sinus

Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Mie University, Tsu city, Mie, 514-8507, Japan

Received 6 November 2000; accepted 13 November 2000.

Abstract 

We have established four cell lines from a human malignant fibrous histiocytoma. Each cell line had human aneuploid karyotype and DNA aneuploidy. Cells in all lines expressed CD13, CD68 and vimentin but lacked CD11, CD14, CD15, CD16, CD45, HLA class II and other mesenchymal and epithelial markers such as desmin, α-smooth muscle, myoglobin, S-100 protein, and cytokeratin. None of the cells expressed surface IgG or C3 receptor, nor did any of them phagocytose latex particles. The cells reacted with an antibody for prolyl-4-hydroxylase, but no collagen (types I, II, III, or IV) was detected in any of the cell lines. The homogenates of all cell lines had cyclic nucleotide phosphodiesterase 3 activity. Two cell lines produced granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-1α, IL-6 and tumor necrosis factor α, another line produced G-CSF, IL-1α, IL-6 and platelet-derived growth factor (PDGF)-AB, and the remaining cell line produced only PDGF-AB. None of the cells produced transforming growth factor-α. The results indicated that the cell lines were immunophenotypically similar to primitive mesenchymal cells.

Keywords:  Human malignant fibrous histiocytoma cell lines, Maxillary sinus, Histogenesis, Cytokine, Primitive mesenchymal cells

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(01)00004-5

Oral Oncology
Volume 37, Issue 6 , Pages 527-536, September 2001